Related Experiment Video
Updated: Jun 4, 2025
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
7.5K
Early experience of prostate artery embolization: a retrospective single-centre study
Emir Majbar1, Jakob Swanberg2, Farhood Alamdari3
1Department of Urology, Västmanland Hospital, Västerås, Sweden; Center for Clinical Research Västmanland, Uppsala University, Sweden. emir.majbar@regionvastmanland.se.
Scandinavian Journal of Urology
|January 2, 2025
Summary
Prostate artery embolization (PAE) offers a viable treatment for benign prostatic hyperplasia (BPH), providing significant symptom relief and catheter freedom for most patients. This minimally invasive option shows promise as an effective alternative to traditional surgical interventions.
Area of Science:
- Interventional Radiology
- Urology
- Vascular Medicine
Background:
- Benign prostatic hyperplasia (BPH) is a common condition affecting aging men.
- Pharmacological treatments like alpha-blockers and 5-alpha-reductase inhibitors are standard BPH management.
- Minimally invasive procedures are increasingly sought as alternatives to traditional surgery.
Purpose of the Study:
- To evaluate the early clinical outcomes of prostate artery embolization (PAE).
- To assess PAE's effectiveness in patients with benign prostatic hyperplasia (BPH).
- To determine symptom relief and catheter independence rates following PAE.
Main Methods:
- Retrospective analysis of 96 patients undergoing PAE for BPH between 2018-2021.
- Data collection included demographics, International Prostate Symptom Score (IPSS), and PSA levels.
- Clinical success defined as IPSS reduction ≤3 points or catheter freedom.
Main Results:
- 63% of patients achieved clinical success after PAE.
- Catheter freedom was achieved in 53% of catheterized patients.
- 79% of non-catheterized patients experienced clinical success, with no significant difference based on median lobe presence.
Conclusions:
- Prostate artery embolization (PAE) is a viable treatment for BPH.
- PAE provides substantial symptom relief and catheter freedom for a majority of patients.
- Further research is warranted to optimize patient selection for PAE.
